Registro:

Referencias:

• Agid, Y., Javoy, F., Glowinski, J., Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat (1973) Nature, 245, pp. 150-151
• Arnt, J., Behavioural stimulation is induced by separate dopamine D1 and D2 receptor sites in reserpine-pretreated but not in normal rats (1985) Eur J Pharmacol, 113, pp. 79-88
• Arnt, J., Hyttel, J., Differential inhibition by dopamine D1 and D2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6- hydroxydopamine lesions (1984) Eur J Pharmacol, 102, pp. 349-354
• Arnt, J., Hyttel, J., Differential involvement of dopamine D1 and D2 receptors in the circling behavior induced by apomorphine, SK and F 38393, pergolide and LY 171555 in 6-OHDA lesioned rats (1985) Psychopharmacology, 85, pp. 346-352
• Barone, P., Davis, T.A., Braun, A.R., Chase, T.N., Dopaminergic mechanisms and motor function: Characterization of D1 and D2 dopamine receptor interactions (1986) Eur J Pharmacol, 123, pp. 109-114
• Bédard, P.J., Boucher, R., Effect of D1 stimulation in normal and MPTP monkeys (1989) Neurosci Lett, 104, pp. 223-228
• Bédard, P.J., Gomez-Mancilla, B., Blanchet, P., Gagnon, C., Dipaolo, T., Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys (1993) Adv Neurol, 60, pp. 113-118
• Blanchet, P., Bédard, P.J., Britton, D.R., Kebabian, J.W., Differential effect of selective D1 and D2 dopamine receptor agonists on levodopa-induced dyskinesia in MPTP monkeys (1993) J Pharmacol Exp Ther, 267, pp. 275-279
• Braun, A., Fabbrini, G., Mouradian, M.M., Serrati, C., Barone, P., Chase, T.N., Selective D1 dopamine receptor agonist treatment of Parkinson's disease (1987) J Neural Transm, 68, pp. 41-50
• Carlson, J.H., Bergstrom, D.A., Walters, J.R., Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: A neurophysiological study (1987) Brain Res, 400, pp. 205-218
• Carman, L.S., Gage, F.H., Shults, C.W., Partial lesion of the substantia nigra: Relation between extent of lesion and rotational behavior (1991) Brain Res, 553, pp. 275-283
• Clark, D., White, F.J., D1 dopamine receptor-The search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications (1987) Synapse, 1, pp. 347-388
• Close, S.P., Marriott, A.S., Pay, S., Failure of SKF 38393-A to relieve parkinsonian symptoms induced by MPTP in the marmoset (1985) Br J Pharmacol, 85, pp. 320-322
• Colosimo, C., Merello, M., Hughes, A.J., Sieradzan, K., Les, A.J., Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: Implications for the pathogenesis of the on-off phenomenon (1996) J Neurol Neurosurg Psychiatry, 61, pp. 634-637
• Domino, E.F., Sheng, J., Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys (1993) J Pharmacol Exp Ther, 265, pp. 1387-1391
• Dravid, A., Jaton, A.L., Enz, A., Frei, P., Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra (1984) Brain Res, 311, pp. 361-365
• Gershanik, O., Heikkila, R.E., Duvoisin, R.C., Effects of dopamine depletion on rotational behavior to dopamine agonists (1983) Brain Res, 261, pp. 358-360
• Goldstein, M., Lieberman, A., Meller, E., A possible molecular mechanism for the antiparkinsonian action of bromocriptine in combination with levodopa (1985) Trends Pharmacol Sci, 6, pp. 436-437
• Goldstein, M., Lieberman, A., Meller, E., Goldstein et al. reply (1986) Trends Pharmacol Sci, 7, pp. 225-228
• Gómez-Mancilla, B., Bédard, P.J., Effect of D1 and D2 agonists and antagonists on dyskinesia produced by L-DOPA in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine trated monkeys (1991) J Pharmacol Exp Ther, 259, pp. 409-413
• Hefti, F., Melamed, E., Wurtman, R.J., Partial lesions of the dopaminergic nigrostriatal system in rat brain: Biochemical characterization (1980) Brain Res, 195, pp. 123-137
• Jackson, D.M., Hashizume, M., Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D1 receptors (1987) J Neural Transm, 69, pp. 131-145
• Kebabian, J.W., Britton, D.R., Deninno, M.P., Perner, R., Smith, L., Jenner, P., Schoenleber, R., Williams, M., A-77636: A potent selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets (1992) Eur J Pharmacol, 229, pp. 203-209
• König, J.F.R., Klippel, R.A., (1963) The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem, , Williams & Wilkins, New York
• Luquin, M.R., Lagerna, J., Herrero, T., Obeso, J.A., CY-208243 anti-parkinsonian effect in MPTP-treated monkeys is mediated by D1 receptor activation (1990) Mov Disorders, 5, p. 78
• Luquin, M.R., Guillen, J., Martinez-Vila, E., Laguna, J., Martinez-Lage, J.M., Functional interaction between dopamine D1 and D2 receptors in "MPTP" monkeys (1994) Eur J Pharmacol, 253, pp. 215-224
• Mashurano, M., Waddington, J.R., Stereotyped behaviour in response to the selective D2 dopamine receptor agonist Ru 24213 is enhanced by treatment with the selective D1 agonist SKF 38393 (1986) Neuropharmacology, 25, pp. 947-949
• Nomoto, M., Jenner, P., Marsden, C.D., The dopamine D2 agonist LY-131865 but not the D1 agonist SKF 38393 reverses parkinsonism induced by 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset (1985) Neurosci Lett, 57, pp. 37-44
• Robertson, G.S., Robertson, H.A., Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats (1986) Brain Res, 384, pp. 387-390
• Robertson, H.A., Robertson, G.S., The antiparkinson action of bromocriptine in combination with levodopa (1986) Trends Pharmacol Sci, 7, pp. 224-227
• Robertson, H.A., Robertson, G.S., Combined L-Dopa and bromocriptine therapy for Parkinson's disease: A proposed mechanism of action (1987) Clin Neuropharmacol, 10, pp. 384-387
• Schwarcz, R., Fuxe, K., Agnati, L.F., Hökfelt, T., Coyle, J.T., Rotational behaviour in rats with unilateral striatal kainic acid lesions: A behavioural model for studies on intact dopamine receptors (1979) Brain Res, 170, pp. 485-495
• Schwartz, J.C., Giros, B., Martres, M.P., Sokoloff, P., The dopamine receptor family: Molecular biology and pharmacology (1992) Semin Neurosci, 4, pp. 99-108
• Shiosaki, K., Jenner, P., Asin, K.E., ABT-431: The diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease (1996) J Pharmacol Exp Ther, 276, pp. 150-160
• Sonsalla, P.K., Manzino, L., Heikkila, R.E., Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway (1988) J Pharmacol Exp Ther, 247, pp. 180-185
• Taylor, J.R., Lawrence, M.S., Redmond Jr., D.E., Elsworth, J.D., Roth, R.H., De Nichols, Mailman, R.B., Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys (1991) Eur J Pharmacol, 199, pp. 389-391
• Telmet, J.A., Chang, P.N., Oertel, W.H., Jenner, P., Marsden, C.D., The D1 dopamine receptor partial agonist CY-208243 exhibit antiparkinsonian activity in the MPTP-treated marmoset (1988) Eur J Pharmacol, 156, p. 197
• Ungerstedt, U., Arbuthnott, G.W., Quantitative recording of rotational behavior in rats after 6-OHDA lesions of the nigrostriatal dopamine system (1970) Brain Res, 24, pp. 485-493
• Waddington, J.L., Bromocriptine, selective D2 dopamine receptor agonists and D1 dopaminergic tone (1986) Trends Pharmacol Sci, 7, pp. 223-224
• Waddington, J.L., O'Boyle, K.M., The D1 dopamine receptor and the search for its functional role: From neurochemistry to behaviour (1987) Rev Neurosci, 1, pp. 157-184
• Waddington, J.L., Daly, S.A., McCauley, P.G., O'Boyle, K.M., Levels of functional interaction between D1-like and D2-like dopamine receptor systems (1994) Dopamine Receptors, pp. 511-537. , Niznik HB (eds) Marcel Dekker, New York
• Waddington, J.L., Daly, S.A., Downes, R.P., Deveney, A.M., McCauley, P.G., O'Boyle, K.M., Behavioural pharmacology of 'D1-like' dopamine receptors: Further subtyping, new pharmacological probes and interactions with 'D2-like' receptors (1995) Prog Neuro-Psychopharmacol Biol Psychiatry, 19, pp. 811-831
• Walters, J.R., Bergstrom, D.A., Carlson, J.H., Chase, T.N., Braun, A.R., D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects (1987) Science, 236, pp. 719-722
• Watts, V.J., Lawler, C.P., Gilmore, J.H., Southerland, S.B., Nichols, D.E., Mailman, R.B., Dopamine D1 receptors: Efficacy of full (dihydrexidine) vs partial (SKF-38393) agonists in primates vs rodents (1993) Eur J Pharmacol, 242, pp. 165-172
• Weick, B.G., Walters, J.R., Effects of D1 and D2 dopamine receptors stimulation on the activity of substantia nigra pars compacta neurons in 6-OHDA lesioned rats: D1/D2 coactivation induces potentiated responses (1987) Brain Res, 405, pp. 234-246

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------